What Different AML Subtypes Are More Prevalent in Certain Demographics?
https://vimeo.com/794307429 Are some acute myeloid leukemia (AML) subtypes more common in some demographic groups? Dr. Naval Daver from the University of Texas MD Anderson Cancer Center discusses different forms of…
AML Treatment Approaches Expand for Older and High-Risk Patients
https://vimeo.com/794306507 How have acute myeloid leukemia (AML) treatment approaches expanded for older and high-risk patients? Dr. Naval Daver from the University of Texas MD Anderson Cancer Center shares insight about…
What Promising AML Treatments Are Available for Newly Diagnosed Patients?
https://vimeo.com/794306419 What do newly diagnosed acute myeloid leukemia (AML) patients have for promising treatment options? Dr. Naval Daver from the University of Texas MD Anderson Cancer Center discusses progress in…
How Can We Address Disparities in AML Among Diverse Populations?
https://vimeo.com/792475469 What do acute myeloid leukemia (AML) patients need to know about care disparities? Dr. Catherine Lai from Penn Medicine discusses ethnic disparities and other factors. Learn about factors in…
Long-Term Effects Acute Myeloid Leukemia Patients Should Know
https://vimeo.com/792475443 What do acute myeloid leukemia (AML) need to know about potential long-term effects of treatment? Dr. Catherine Lai from Penn Medicine shares insight. Learn about medical considerations for monitoring…
What Are Some Clinical Predictors for Relapse in Acute Myeloid Leukemia?
https://vimeo.com/792474847 What do acute myeloid leukemia (AML) patients need to know about risk of relapse? Dr. Catherine Lai from Penn Medicine explains her perspective. Learn about relapse risk groups and…
What Does Transfusion Burden Mean in Acute Myeloid Leukemia?
https://vimeo.com/792474680 What do acute myeloid leukemia (AML) patients need to know about transfusion burden? Dr. Catherine Lai from Penn Medicine explains transfusion burden for AML patients. Learn about the range…
Assessing Untreated AML Patients Who Are Ineligible for Intensive Chemotherapy
https://vimeo.com/792474641 How are acute myeloid leukemia (AML) patients assessed for intensive chemotherapy? Dr. Catherine Lai from Penn Medicine explains eligibility criteria. Learn factors that impact patient eligibility and treatment options…
What AML Treatment Options Are Available for MRD-Positive Patients?
https://vimeo.com/792474010 For acute myeloid leukemia (AML) patients who are MRD-positive, what treatment options are available? Dr. Catherine Lai from Penn Medicine discusses MRD-positive concerns. Learn about recent guideline updates for…
What Is MRD-Positive Acute Myeloid Leukemia?
https://vimeo.com/792473929 What do acute myeloid leukemia (AML) patients need to know about MRD-positive AML? Dr. Catherine Lai from Penn Medicine discusses minimal residual disease (MRD). Learn about the meaning of…
What Is FLT3-Mutated Acute Myeloid Leukemia?
https://vimeo.com/792473811 Some acute myeloid leukemia (AML) patients may have an FLT3 mutation. Dr. Catherine Lai from Penn Medicine shares insight about the two types of FLT3 mutation, treatment options for…
What Are the Latest Acute Myeloid Leukemia Therapies?
https://vimeo.com/792473744 What are the latest treatments in acute myeloid leukemia (AML)? Dr. Catherine Lai from Penn Medicine discusses the increase in available AML treatments. Learn about combination therapies and treatment…